Angze Li, Jun Wang, Wei Zhu, Muqing Liu* and Shangfeng Liu*,
{"title":"新型负空气(氧)离子储放产品的原理与应用。","authors":"Angze Li, Jun Wang, Wei Zhu, Muqing Liu* and Shangfeng Liu*, ","doi":"10.1021/acs.molpharmaceut.5c00361","DOIUrl":null,"url":null,"abstract":"<p >Negative air ions (NAI) are ions present in the air that enhance blood oxygen absorption and utilization, stimulate metabolism, and modulate mood and nervous system activity. However, the application of NAI has been limited by storage challenges and low concentrations due to the conditions under which they are produced and the nature of the ions themselves. In order to overcome these limitations and develop NAI as a viable method of treatment, we have introduced a novel, highly concentrated NAI prodrug that incorporates NAI into flaxseed oil. This innovative drug can be administered in liquid, semiliquid, and dietary forms. Additionally, we have explored various NAI-related actions and mechanisms, such as the antiaging effects of these drugs through ROS inhibition. Our research has shown that NAI agents can penetrate the brain through the skin and the blood–brain barrier, rapidly reoxygenating cells throughout the body. Particularly, NAI has demonstrated excellent antitumor and cognitive-enhancing properties. These findings have significant implications for the potential of our NAI-based prodrug as a groundbreaking approach in antiaging therapy, providing a novel strategy for enhancing endogenous oxygenation and treating respiratory compromise and beyond.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":"22 9","pages":"5400–5409"},"PeriodicalIF":4.5000,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Principle and Application of Novel Negative Air (Oxygen) Ion Storage and Release Products\",\"authors\":\"Angze Li, Jun Wang, Wei Zhu, Muqing Liu* and Shangfeng Liu*, \",\"doi\":\"10.1021/acs.molpharmaceut.5c00361\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Negative air ions (NAI) are ions present in the air that enhance blood oxygen absorption and utilization, stimulate metabolism, and modulate mood and nervous system activity. However, the application of NAI has been limited by storage challenges and low concentrations due to the conditions under which they are produced and the nature of the ions themselves. In order to overcome these limitations and develop NAI as a viable method of treatment, we have introduced a novel, highly concentrated NAI prodrug that incorporates NAI into flaxseed oil. This innovative drug can be administered in liquid, semiliquid, and dietary forms. Additionally, we have explored various NAI-related actions and mechanisms, such as the antiaging effects of these drugs through ROS inhibition. Our research has shown that NAI agents can penetrate the brain through the skin and the blood–brain barrier, rapidly reoxygenating cells throughout the body. Particularly, NAI has demonstrated excellent antitumor and cognitive-enhancing properties. These findings have significant implications for the potential of our NAI-based prodrug as a groundbreaking approach in antiaging therapy, providing a novel strategy for enhancing endogenous oxygenation and treating respiratory compromise and beyond.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":\"22 9\",\"pages\":\"5400–5409\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-08-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00361\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.5c00361","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
空气负离子(Negative air ions, NAI)是一种存在于空气中的离子,它能促进血氧的吸收和利用,刺激新陈代谢,调节情绪和神经系统的活动。然而,由于它们产生的条件和离子本身的性质,NAI的应用受到存储挑战和低浓度的限制。为了克服这些限制和发展NAI作为一种可行的治疗方法,我们已经推出了一种新的,高度浓缩的NAI前药,将NAI纳入亚麻籽油中。这种创新药物可以以液体、半液体和膳食形式给药。此外,我们还探索了各种nai相关的作用和机制,例如这些药物通过抑制ROS的抗衰老作用。我们的研究表明,NAI药剂可以通过皮肤和血脑屏障穿透大脑,迅速给全身的细胞再充氧。特别是,NAI具有优异的抗肿瘤和增强认知的特性。这些发现对我们基于naii的前药作为抗衰老治疗的突破性方法具有重要意义,为增强内源性氧合和治疗呼吸衰竭等提供了一种新的策略。
Principle and Application of Novel Negative Air (Oxygen) Ion Storage and Release Products
Negative air ions (NAI) are ions present in the air that enhance blood oxygen absorption and utilization, stimulate metabolism, and modulate mood and nervous system activity. However, the application of NAI has been limited by storage challenges and low concentrations due to the conditions under which they are produced and the nature of the ions themselves. In order to overcome these limitations and develop NAI as a viable method of treatment, we have introduced a novel, highly concentrated NAI prodrug that incorporates NAI into flaxseed oil. This innovative drug can be administered in liquid, semiliquid, and dietary forms. Additionally, we have explored various NAI-related actions and mechanisms, such as the antiaging effects of these drugs through ROS inhibition. Our research has shown that NAI agents can penetrate the brain through the skin and the blood–brain barrier, rapidly reoxygenating cells throughout the body. Particularly, NAI has demonstrated excellent antitumor and cognitive-enhancing properties. These findings have significant implications for the potential of our NAI-based prodrug as a groundbreaking approach in antiaging therapy, providing a novel strategy for enhancing endogenous oxygenation and treating respiratory compromise and beyond.
期刊介绍:
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.